How CRISPR shapes the future of disease diagnosis and treatment

How CRISPR shapes the future of disease diagnosis and treatment

Dr Tamara Sunbul of Johns Hopkins Aramco Healthcare talked about the promising application of gene editing in healthcare but also cautions on uncertainties.

Read on

Medigy Insights

Dr. Tamara Sunbul of Johns Hopkins Aramco Healthcare discussed the promising potential of gene editing in healthcare during her keynote session, emphasizing the importance of collecting genetic data over time for precision medicine. She highlighted the variability in patient responses to medications and the need for digital technologies like gene editing to detect abnormalities.

Dr. Sunbul highlighted CRISPR-Cas9 as a cutting-edge gene editing tool with applications in digital diagnostics and therapeutics. She mentioned its use in rapid disease detection methods like SHERLOCK and DETECTR, as well as its integration into drug discovery processes by companies such as Atomwise, Deep Genomics, and Valo.

Furthermore, gene editing has shown significant progress in advancing treatments for various conditions, including blood disorders, Down syndrome, hereditary blindness, cystic fibrosis, muscular dystrophy, and more. CRISPR has enabled the reprogramming of patients' immune systems to target cancer, infections, and chronic diseases.

However, Dr. Sunbul also cautioned about the ethical, legal, and scientific complexities associated with gene editing. She stressed the potential risks and irreversible consequences, emphasizing that decisions made today will impact future generations.


Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 23, 2024 at 3:57am